Patents by Inventor Roy Victor Davies

Roy Victor Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Condensed thiazole derivatives, having 5-HT receptor affinity
    Patent number: 5869492
    Abstract: Compounds of formula I ##STR1## in which A is S(O).sub.p or O;p is 0, 1 or 2;g is 0, 1, 2, 3, or 4;n is 2 or 3; andR.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are optional substituents have utility in the treatment of central nervous system disorders, for example depression, anxiety, psychoses (for example schizophrenia), tardive dyskinesia, obesity, drug addiction, drug abuse, cognitive disorders, Alzheimer's disease, senile dementia, cerebral ischemia, obsessive-compulsive behavior, panic attacks, social phobias, eating disorders and anorexia, non-insulin dependent diabetes mellitus, hyperglycemia, and stress.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: February 9, 1999
    Assignee: Knoll Aktiengesellschaft
    Inventors: Frank Kerrigan, Sharon Crawford Cheetham, Roy Victor Davies
  • Azolyl-cyclic amine derivates with immunomodulatory activity
    Patent number: 5741800
    Abstract: A compound of the formula (I), ##STR1## as defined in the specification, having immunomodulatory activity, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the compound, and processes to make and to use the compound are described.
    Type: Grant
    Filed: December 21, 1995
    Date of Patent: April 21, 1998
    Assignee: Knoll Aktiengesellachaft
    Inventors: David George Webber, Gerald Bernard Tometzki, Michael Henry Hockley, Roger Bernard Titman, Roy Victor Davies, Paul Anthony Bradley